Thomas J Hoerger1. 1. Public Health Economics Program, RTI International, 3040 Cornwallis Road, Research Triangle Park, Durham, NC, 27709, USA. tjh@rti.org.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to provide current synthesis of the evidence on the cost-effectiveness of bariatric surgery for persons with diabetes. RECENT FINDINGS: Virtually, every study that has evaluated the cost-effectiveness of bariatric surgery for persons who are obese and have type 2 diabetes has concluded that surgery is cost-effective. A few studies outside the USA found that surgery is cost-saving. Currently, most but not all US insurers cover bariatric surgery in persons with type 2 diabetes and BMI ≥ 35 kg/m2. Bariatric surgery is a cost-effective treatment for persons with type 2 diabetes and BMI ≥ 35 kg/m2. There is interest in extending surgery to persons with diabetes and lower BMI; the cost-effectiveness of treating these individuals with bariatric surgery should be explored. Despite the potential benefits, not all obese or overweight persons with diabetes will choose surgery.
PURPOSE OF REVIEW: The purpose of this review is to provide current synthesis of the evidence on the cost-effectiveness of bariatric surgery for persons with diabetes. RECENT FINDINGS: Virtually, every study that has evaluated the cost-effectiveness of bariatric surgery for persons who are obese and have type 2 diabetes has concluded that surgery is cost-effective. A few studies outside the USA found that surgery is cost-saving. Currently, most but not all US insurers cover bariatric surgery in persons with type 2 diabetes and BMI ≥ 35 kg/m2. Bariatric surgery is a cost-effective treatment for persons with type 2 diabetes and BMI ≥ 35 kg/m2. There is interest in extending surgery to persons with diabetes and lower BMI; the cost-effectiveness of treating these individuals with bariatric surgery should be explored. Despite the potential benefits, not all obese or overweight persons with diabetes will choose surgery.
Authors: David P Fisher; Eric Johnson; Sebastien Haneuse; David Arterburn; Karen J Coleman; Patrick J O'Connor; Rebecca O'Brien; Andy Bogart; Mary Kay Theis; Jane Anau; Emily B Schroeder; Stephen Sidney Journal: JAMA Date: 2018-10-16 Impact factor: 56.272
Authors: William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan Journal: N Engl J Med Date: 2002-02-07 Impact factor: 91.245
Authors: Thomas J Hoerger; Ping Zhang; Joel E Segel; Henry S Kahn; Lawrence E Barker; Steven Couper Journal: Diabetes Care Date: 2010-09 Impact factor: 17.152
Authors: Thomas H Inge; Anita P Courcoulas; Todd M Jenkins; Marc P Michalsky; Michael A Helmrath; Mary L Brandt; Carroll M Harmon; Meg H Zeller; Mike K Chen; Stavra A Xanthakos; Mary Horlick; C Ralph Buncher Journal: N Engl J Med Date: 2015-11-06 Impact factor: 91.245
Authors: Paul E O'Brien; Annemarie Hindle; Leah Brennan; Stewart Skinner; Paul Burton; Andrew Smith; Gary Crosthwaite; Wendy Brown Journal: Obes Surg Date: 2019-01 Impact factor: 4.129
Authors: Brianna N Lauren; Francesca Lim; Abraham Krikhely; Elsie M Taveras; Jennifer A Woo Baidal; Brandon K Bellows; Chin Hur Journal: JAMA Netw Open Date: 2022-02-01